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1. Introduction 
A wide variety of emerging and re-emerging viruses (e.g. arboviruses, ‘arthropod-borne 
viruses’) contributes to neurological diseases. Infections can be associated with new viral 
variants that are more efficiently transmitted and lead to massive outbreak and increased 
reports of complicated cases involving the CNS (Tsetsarkin et al., 2007; Vazeille et al., 2007). 
It is also possible that viruses may have acquired increased neurovirulence by a previously 
non-neurotropic virus. Viruses that appear to have recently become more neurovirulent 
include for example the West Nile flavivirus (WNV), Chikungunya alphavirus (CHIKV) and 
the enterovirus 71 (ENV71) (Griffin, 2010). In addition to these newer challenges, Japanese 
encephalitis flavivirus (JEV), rabies, polio, measles virus (MV), human immunodeficiency 
virus (HIV) and human herpes virus (HHV) remain important causes of neurologic diseases. 
Focusing on CHIKV, this is an alphavirus of the Togaviridae family transmitted by 
mosquitoes of the Aedes (Ae) genus. The alphavirus group comprises 29 viruses, six of 
which of the ‘Old World, ie Africa’ can cause human joint disorders (arthralgia evolving to 
arthritis), namely CHIKV, O’nyong-nyong virus (ONNV), Semliki forest virus (SFV), Ross 
River (RRV), Sindbis virus (SINV), Mayaro virus (MAYV) while the so-called ‘New World’ 
such as Eastern equine encephalitis virus (EEEV) and Venezuelan equine encephalitis virus 
(VEEV) can cause severe brain damage (Das et al., 2010; Jaffar-Bandjee et al., 2009). 
Interestingly, CHIKV-associated neuropathology was first described in the 1960s but it is the 
unprecedented incidence rate in the Indian Ocean with efficient clinical facilities that 
allowed a better description of cases with severe encephalitis, meningoencephalitis, 
peripheral neuropathies and deaths among newborns (mother-to-child infection), infants 
and elderly patients (Das et al., 2010; Jaffar-Bandjee et al., 2009). The follow-up of the 
neonates contaminated by CHIKV clearly indicates poor outcomes and neurodevelopment 
defects (Jaffar-Bandjee et al., 2011). Neurological manifestations described in  
adults requiring hospitalization involved cases of encephalopathy frequently associated 
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with the presence of IgM anti-CHIKV in the CSF, encephalitis, Guillain-Barre, 
encephalomyeloradiculitis and rare deaths (Economopoulou et al., 2009; Lemant et al., 2008). 
In recent histopathological studies, CHIKV infection in adults was associated with bilateral 
frontoparietal white matter lesions with restricted diffusion, which is described as an early 
sign of viral encephalitis (Ganesan et al., 2008). Focal perivascular lymphocytic infiltrates 
were also present in area of active demyelination and some degree of microglial activation 
was also noted in the gray matter which may contribute to bystander neuronal loss 
(Ganesan et al., 2008). Although data are still scarce, the number of cases with CNS 
involvement appears to support the neurotropic/neuroinfectious activity of CHIKV. This 
unique CNS infection illustrated by subventricular white matter lesions and 
intraparenchymal haemorrhages have been confirmed experimentally. CHIKV diseases can 
be reproduced in several animal models and the virus was shown to infect mouse/macaque 
brains and to replicate in cultures of glial and neuronal cells (Gardner et al., 2010; Labadie et 
al., 2010; Solignat et al., 2009; Wang et al., 2008; Ziegler et al., 2008). The incidence of 
neuroinfection is dramatically increased following either the injection of high viral titers, the 
route of injection (intranasal > intraperitoneal), in young animals (less than two week-old) 
or in mice failing to mount a robust interferon response (i.e. IFNAR knockout animals). 
Thus, experimental infections where mice were inoculated subcutaneously showed rapid 
and robust replication (106-107 PFU/ml) of CHIKV in the brain particularly of newborn 
mice. Interestingly, infected mice showed signs of illness suggestive of human clinical 
pathology such as loss of balance, difficulty of walking, dragging of the hind limbs, skin 
lesions but with rare mortality. CHIKV neuroinfection is particularly severe in IFNAR -/- 
mice and targets the leptomeninges, the choroid plexus and ependymal cells lining the 
subventricular zone (SVZ) also known as one of the neural stem cell niche in adult brains. 
The nature of the receptor(s) mediating cell attachment and infection remains to be 
characterized but the role of apoptotic blebs carrying the virus from cell to cell has recently 
been established as in a Trojan-horse paradigm (see below). On the one hand, the local 
innate immune response is the key to the control of viral infection but could also, on the 
other, contribute to neuronal loss through the uncontrolled release of cytotoxic 
inflammatory cytokines, complement proteins or proapoptotic molecules (TNF-, FasL, 
granzymes) (Hauwel et al., 2005). We will review herein the pathological mechanisms as 
well as the innate immune mechanisms engaged during encephalitis and with special 
emphasis on chikungunya. 
2. Encephalitis and clinical manifestations 
The clinical hallmark of acute viral encephalitis includes classically fever, headache, and 
altered level of consciousness. Other associated clinical observations are disorientation, 
behavioral and speech disturbances and seizures. These clinical signs distinguish a patient 
with encephalitis from one with viral meningitis, who can have headache, nuchal rigidity, 
and fever (Whitley and Gnann, 2002). Clinical findings reflect disease progression and the 
specific areas of CNS involvement, which is determined by the tropism of different viruses 
for different cell types expressing different viral receptors. Neurons are most likely to be 
targeted by several viruses such as polioviruses which preferentially infect motor neurons 
and rabies which selectively infects neurons of the limbic system (Griffin, 2010). 
Oligodendrocytes, the myelin-forming cells can also be infected (e.g. HHV6, SFV) and 
leading to direct or indirect demyelination (Fazakerley et al., 2006; Mock et al., 1999). Other 
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cells within the CNS can also be the site of viral replication and for instance with mumps 
virus which can infect epithelial cells of the choroid plexus. The involvement of ependymal 
cells of the SVZ can result in hydranencephaly following infection for instance by 
adenoviruses or coxsackie viruses.  
Viruses vary greatly in their capacity to induce encephalitis. For some viruses (e.g. mumps), 
neuroinfection is a common but a relatively benign part of the syndrome. 
For others (flaviviruses such as JEV or WNV), although the infection is highly 
asymptomatic, CNS infection when it occurs is the most prominent clinical feature. A third 
group of viruses are those which commonly cause infection, but only rarely cause 
encephalitis (herpes simplex virus, HSV or CHIKV). In this group, newborns and elderly 
patients are at risk because they either have a poor or inappropriate immune response 
against the infectious challenge (Hoarau et al., 2010).  
A paramyxovirus isolated from a Malaysian patient with encephalitis showed in vitro 
characteristics similar to Hendra virus (HeV), a new morbillivirus previously isolated from 
horses and human in 1995. Subsequent virological studies have shown that the Malaysian 
pathogen, now named Nipah virus (NiV), is closely related to, but distinct from HeV and 
that the two belong to a new genus within the family paramyxoviridae capable of causing 
major outbreaks of encephalitis. Patients present with fever, headache, dizziness, vomiting, 
and altered mental state.  
Finally, there are viruses for which human infection inevitably and exclusively results in 
CNS disease (e.g. rabies). In addition to acute pathology, other viruses (e.g. measles) can 
cause syndromes of post-infectious encephalopathy with the capacity of the virus to hide 
into tissue sanctuaries. The capacity of these viruses to reactivate the viral cycle is poorly 
understood and may be the results of immune escape mechanisms.  
3. Molecular and cellular mechanisms for virus entry into the CNS 
The clinical manifestations of many virus infections are dependent on whether or not virus 
gains access to susceptible cells within the CNS. Therefore, the mechanisms by which 
viruses penetrate the CNS are of prime importance in understanding the pathogenesis of the 
disease. To understand the invasion process it is necessary to describe one of the defensive 
structures that prevent microbial invasion. The CNS is enclosed completely by three 
different but connected blood-brain interfaces (Abbott et al., 2010). 
A blood -brain barrier (BBB) composed of brain micro-vascular endothelial cells (BMEC) 
with intercellular tight junctions and supported by astrocytes, pericytes and the basement 
membrane. The second is highly vascularized and fenestrated barrier localized at the 
choroid plexus between blood and cerebrospinal fluid (CSF), which also allows passage of 
some blood components and, thirdly, an interface provided by avascular arachnoid 
epithelium, underlying the dura, and completely enclosing the CNS (Abbott et al., 2010; 
Weiss et al., 2009). 
There are at least four different mechanisms by which viruses can gain access into the CNS. 
First, viruses may gain access by infecting the BMEC or may be transported across the 
BMEC (Jarvis and Nelson, 2002). Infection of the BMEC may provide a portal for viral entry 
into the CNS and disrupting the BBB function. A number of viruses such as 
cytomegalovirus (CMV) (Jarvis and Nelson, 2002), HIV (Moses et al., 1993) and arboviruses 
(Dropulic and Masters, 1990) are able to infect the BMEC at least in vitro. In acute viral 
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encephalitis, capillary and endothelial inflammation of cortical vessels is a striking 
pathological finding, occurring primarily in the grey matter or grey white junction and this 
observation may facilitate virus entry. For example, HIV may gain access to CNS in vivo by 
this paracellular route as a result of endothelium activation by TNF┙ and other 
proinflammatory cytokines (Fiala et al., 1997). 
Second, viruses may transmigrate across the BBB within virally infected leukocytes. For 
HIV, several studies suggest that virus shedding from infected CD4+ T cells, macrophages, 
and monocytes during migration through the BBB can instigate CNS replication into the 
parenchyma (Nottet et al., 1996; Persidsky et al., 1997; Schmidtmayerova et al., 1996). CMV 
can also be transferred to CNS by virus infected mononuclear phagocytes and bi-directional 
cell to cell transmission between infected monocytes and endothelial cells (Drevets and 
Leenen, 2000). 
Third, viruses can also penetrate the CNS by taking advantage of incomplete closure of the 
BBB. Despite the intercellular tight junctions between the capillary endothelial cells in most 
regions of the BBB, certain areas of the CNS such as the choroid plexus, posterior pituitary, 
and circumventricular organs are not completely protected by the BBB due to a fenestrated 
endothelial cell layer and sparse basement membrane (Zhang and Tuomanen, 1999). A 
number of blood-borne viruses including mumps (Herndon et al., 1974), HIV (Bagasra et al., 
1996) and CHIKV (Couderc et al., 2008) have been suggested to penetrate across the choroid 
plexus micro- vessels and infect the epithelium. In the CSF space, viruses can subsequently 
infect the ependymal cells and the surrounding brain tissue. 
Finally, viruses can spread to the CNS through peripheral neuronal routes, like the motor 
neurons of the spinal cord ,olfactory neurons, retinal neurons, oculomotor neurons and 
trigeminal nerves , which are directly connected to the CNS, thus providing a convenient 
route for neurotropic viruses (Mori et al., 2005; Tirabassi et al., 1998). Viruses including HSV 
(Barnett et al., 1993), rabies virus (Jackson, 2003) and VEEV (Charles et al., 1995) are able to 
replicate within peripheral nerves and are transported into the CNS from the PNS along 
axons as the result of axonal transport of neurons. Certain enteroviruses can also spread to 
the CNS by infecting enteric neurons (Morrison and Fields, 1991). Virus spread within the 
CNS by retrograde, anterograde or cell to cell diffusion mechanisms. 
4. Infection and replication of viruses in brain cells 
4.1 Primary receptors used by viruses to infect CNS cells 
The presence of cell membrane proteins that act as virus receptors determines whether a cell 
can be invaded by a virus or not. Dependent on the receptor(s) chosen, some viruses may 
infect nearly all mammalian cell types or only a small subset of cells from certain species. 
We herein have chosen to highlight only some of the receptors used by a few emerging or 
re-emerging viruses to infect specific cell types in the brain and to cause encephalitis. 
Several comprehensive reviews have discussed the role of different receptors for rabies 
(Acethylcholine nicotinic receptors, NCAM CD56 as well as the P75 neurotrophin receptor, 
NTR) (Lafon, 2005) and, hence, this aspect will not be discussed herein.  
4.1.1 Nectin-1 and 2 are cellular receptors for HSV 
Nectins are immunoglobulin (Ig)-like Cell Adhesion Molecules (CAMs) involved in the 
formation of various intercellular junctions and the establishment of apical-basal polarity at 
cell-cell adhesion sites (Takai et al., 2008). The nectin family which comprises 4 members, 
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nectin-1 or poliovirus receptor related 1 (PRR1 also called HveC, CD111, HIgR), nectin-2 
(also termed PRR2, HveB, CD112), nectin-3 and nectin-4. Each of them contains an 
extracellular region with three Ig-like domains, a single transmembrane region, and a 
cytoplasmic tail region. Nectin-1, -2 and -3 are expressed ubiquitously in multiple cell types 
such as epithelia, fibroblasts and neurons, whereas nectin-4 is mainly expressed in the 
human placenta. Nectin-1 and -2 have been identified as HSV entry mediators (Hve) (see 
Table 1). Nectin-1 can serve as entry receptors for both HSV-1 and HSV-2 (Geraghty et al., 
1998). In contrast, nectin-2 has more limited entry activity. Indeed, human nectin-2 is only a 
weak entry receptor for HSV-2 and certain strains of HSV-1 carrying out mutations in the 
glycoprotein D (Lopez et al., 2000). A more recent study also assessed the roles of the two 
known entry receptors, HVEM and nectin-1, in neuronal infection in the CNS and the 
development of encephalitis in a mouse model (Kopp et al., 2009). Intracranial injection of 
HSV was performed directly into the hippocampus of Wild-type (WT), HVEM KO, nectin-1 
 
Name HSV Rabies HIV Polio WNV CHIKV 
Virus family 
Alpha 
herpesvirus 
Rhabdovirus Retrovirus 
Picorna 
virus 
Flavivirus Alphavirus 
Genome 
(+)DNA 
double 
stranded 
linear 
(-)RNA single 
stranded 
linear 
(+)RNA 
single 
stranded 
linear 
(+)RNA 
single 
stranded 
linear 
(+)RNA 
single 
stranded 
linear 
(+)RNA 
Single stranded 
linear 
Envelope yes yes yes No yes yes 
Route of 
brain entry 
Trigeminal 
Nerve 
Olfactory 
nerve 
Retrograde 
axonal 
Cell 
mediated 
BBB crossing
Retrograde
Axonal 
+ BBB 
crossing 
Direct BBB 
crossing 
Blood- CSF 
crossing 
Receptors 
Nectin-1, 
Nectin-2, 
HSPG 
NCAM 
(CD56) 
AChR 
P75 NTR 
 
CD4, CCR5,
CXCR4 
 
Nectin-
1(PRR1), 
Nectin-
2(PRR2) 
DC-SIGN 
(myeloid 
cells) 
Apoptotic bleb-
mediated cell 
entry 
Targets 
(CNS) 
Neurons Neurons 
Myeloid cells
microglia 
Neurons 
Myeloid cells
Microglia 
Epithelial cells 
Ependymal cells 
Neurons 
Glia 
Clinics 
Encephalitis
Herpetic 
neuralgia 
Meningitis 
Myelitis 
Guillain 
Barre like 
syndrome 
Progressive 
encephalitis 
paralysis 
Dementia 
Encephalitis
Myelitis 
Neuropathy
Paralysis 
Respiratory 
arrest 
Encephalitis
Meningitis 
Myopathy 
Encephalopathy 
Encephalitis 
Guillain Barre 
 
Geographic 
distribution 
Worldwide 
Europe 
Asia 
Africa 
Americas 
Worldwide 
India 
Africa 
Europe 
Americas 
Africa 
Africa 
Asia 
India 
(Europe) 
(Reunion) 
 
(See text for abbreviation) 
Table 1. Encephalitis due to emerging and re-emerging viruses 
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KO and double KO mice. The results indicated that nectin-1 deficient mice showed no signs 
of disease after intracranial inoculation, and no HSV antigens were detectable in the brain 
parenchyma. However, HSV antigens were detected in non-parenchymal cells lining the 
ventricules. In the double KO mice, the results showed an absence of disease and no 
detectable expression of viral antigens even in non-parenchymal cells, indicating that 
infection of these cells in the nectin-1 KO mice was dependent on the expression of HveM.  
4.1.2 CD46 is a cellular receptor for HHV6 and measles  
CD46 also designated as membrane cofactor protein (MCP) is a member of a family of 
glycoproteins acting as regulators of complement activation, but has subsequently been 
shown to link innate immunity to adaptative immunity (Seya et al., 1986). CD46 mediates 
the inactivation of its natural complement ligands C3b and C4b and acts as a cofactor for 
serine protease factor I (Lublin et al., 1988). CD46 thus protect host cells from homologous 
complement attack which could result in extensive cytolysis and widespread tissue damage. 
Another function of CD46 is to promote T cell differentiation from a helper Th1 to a 
regulatory Tr1 phenotype, depending on IL-2 concentrations (Cardone et al., 2010). Human 
CD46 is alternatively spliced into several isoforms, resulting in a varying number of 
extracellular domains and two different cytoplasmic tails, Cyt1 and Cyt2 (Seya et al., 1999). 
CD46 seems to be constitutively recycled from the cell surface via clathrin-coated pits and 
transported to perinuclear multivesicular bodies (Crimeen-Irwin et al., 2003). The 
importance of CD46 in the homeostasis of the organism is highlighted by its ubiquitous 
expression on the surface of all nucleated human cells (Liszewski et al., 1991). 
Human CD46 is a cellular receptor for Human Herpesvirus 6 (HHV-6) (Santoro et al., 1999) 
and MV (Dorig et al., 1993). The authors demonstrated that both acute infection and cell to 
cell fusion mediated by HHV-6 were specifically inhibited by a monoclonal antibody to 
CD46; fusion was also blocked by soluble CD46. Interestingly, they showed that nonhuman 
cells resistant to HHV-6 fusion and entry became susceptible upon expression of 
recombinant human CD46. Concerning the study of MV infection in the CNS, a murine 
model of MV-induced pathology was developed from several lines of transgenic mice 
expressing human CD46 molecule with Cyt1 or Cyt2 (Evlashev et al., 2000). The results of 
their experiments showed that all transgenic mice expressing CD46 protein in the brain 
were highly sensitive to intracerebral infection by the MV Edmonston strain, in comparison 
to nontransgenic controls. In addition, the two isoforms of CD46, Cyt1 and 2, are 
functionally similar in mediating MV entry into the brain.  
4.1.3 Ephrins are cellular receptors for Hendra virus (HeV) and Nipah virus (Niv) 
The Eph (erythropoietin-producing hepatocellular) receptors are the largest family of 
tyrosine kinase receptors (TRKs). They interact with cell surface bound ligands, the ephrins 
(Eph receptor interacting proteins) that are a highly conserved class of proteins with many 
homologous members. Based on structural differences, two classes of ephrins can be 
classified: ephrins-A (A1 to A6) are attached to the plasma membrane via glycophosphatidyl 
inositol (GPI) moiety and ephrins B (B1 to B3) crossing the plasma membrane and 
possessing a short cytoplasmic tail. Eph receptors have diverse functions, such as 
widespread effects on the actin cytoskeleton, cell-substrate adhesion, intercellular junctions, 
cell shape, and cell movement (Egea and Klein, 2007; Himanen et al., 2007; Pasquale, 2005; 
Pasquale, 2008). 
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Two independent studies identified Ephrin B2 (EFNB2) as the receptor for HeV and NiV, 
which are emergent paramyxovirus. Of the ten potential receptor-encoding plasmids they 
used to transfect non-permissive HeLa cells, only the human EFNB2 plasmid confers HeV 
fusion permissiveness. They further demonstrated that soluble EFNB2 blocks both viruses 
fusion in human EFNB2-transfected HeLa cells. They also showed that both HeV and NiV 
glycoprotein G and EFNB2 soluble protein could be specifically and reciprocally captured by 
ELISA. In addition, both viruses glycoprotein G were efficiently coprecipitated by EFNB2/Fc. 
Another study identified EFNB2 as an entry receptor for NiV (Negrete et al., 2005). The 
authors also reported that EFNB2 binds to the NiV glycoprotein G. They observed that 
soluble Fc-fusion proteins of EFNB2 effectively blocked NiV fusion and entry into 
permissive cell types. Moreover, transfection of EFNB2 into non-permissive cells renders 
them permissive for NiV fusion and entry. Interestingly they found that soluble EFNB2 
inhibited NiV-envelope-mediated infection of microvascular endothelial cells and primary 
cortical rat neurons. EFNB3 was later discovered as an additional receptor for NiV using the 
Chinese hamster ovary cell line (CHO-pgsA745) that does not express ephrins 
endogenously (Negrete et al., 2006). Interestingly, the authors characterized the important 
conserved Leu-Trp residues in the G-H loop of EFNB2 and B3 that are critical for their 
binding with NiV glycoprotein G.  
4.1.4 Scavenger receptor class B member 2 (SCARB2) and EV71 
The concept of scavenger receptors (SCAR) was first described by their ability to bind 
modified low-density lipoproteins (Goldstein et al., 1979). SCAR can bind a variety of 
natural/endogenous, modified host, microbial (bacterial, viral, fungal, and parasitic), 
environmental, soluble or particulates ligands by endocytosis and phagocytosis (reviewed 
in (Mukhopadhyay and Gordon, 2004)). SCARB2 (also known as lysosomal integral 
membrane protein II or CD36b like-2) belongs to the scavenger receptor class B subfamily, 
which also includes SCARB1 and CD36 (Calvo et al., 1995; Eskelinen et al., 2003). SCARB2 is 
a type III double-transmembrane protein with N- as well as C-terminal cytoplasmic tails and 
is located primarily in lysosomes and endosomes. SCARB2 participates in membrane 
transportation and the reorganization of the endosomal-lysosomal compartment (Kuronita 
et al., 2002). Deficiency of SCARB2 in mice causes ureteric pelvic junction obstruction, 
deafness and peripheral neuropathy (Gamp et al., 2003). SCARB2 is widely expressed in 
lysosomes and late endosomes (reviewed in (Eskelinen et al., 2003). 
Since its identification in California in 1969 (Schmidt et al., 1974), enterovirus 71 (EV71) has 
been recognized as a frequent cause of epidemics of hand-foot-and-mouth disease (HFMD) 
associated with severe neurological sequelae in some cases (Blomberg et al., 1974). EV71 
infections can progress to aseptic meningitis, acute flaccid paralysis and fatal encephalitis 
(McMinn, 2002). A recent paper demonstrated that SCARB2 is a receptor for EV71 
(Yamayoshi et al., 2009). The authors showed that EV71 binds soluble SCARB2 or cells 
expressing SCARB2, and the binding is inhibited by an antibody to SCARB2. Furthermore, 
expression of human SCARB2 enables normally unsusceptible cell lines to support EV71 
propagation and develop cytopathic effects. Yet, the detail of the interaction between EV71 
and SCARB2 at the cellular level, resulting in CNS infection has not been identified. 
4.1.5 CD4 as the primary receptor for HIV  
Human CD4 exhibits a poly-Ig-like domain structure which is homologous to an 
increasingly large number of recognition molecules, and consists in four tandem variable-
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joining (VJ)-like domains (Maddon et al., 1987). The Ig-like domains of CD4 are anchored to 
the membrane by a hydrophobic segment, and followed by a short cytoplasmic region. CD4 
is expressed on the surface of T lymphocytes, monocytes, macrophages, and brain microglia 
(resident macrophages) (Wyatt and Sodroski, 1998).  
HIV invades the CNS early following viral infection but provokes brain disease only years 
later. During the periods of progressive immunosuppression, neurological disease occurs in 
15 to 20% of infected individuals which develop cognitive and motor impairments referred 
to as the HIV type 1 (HIV-1)-associated dementia complex also termed as HIV-associated 
dementia or HIV encephalopathy (Janssen et al., 1991; Price et al., 1988). Neurological 
disease is often associated with a marked depletion of CD4+ T lymphocytes (Navia et al., 
1986). It is now know that HIV encephalitis is a common pathological manifestation 
characterized by monocyte infiltration into the brain, the formation of macrophage-derived 
multinucleated giant cells, microglial nodules, and demyelination (Sharer et al., 1985).   
Considerable amount of data identified CD4 as the main entry receptor for HIV. Previous 
studies on the two AIDS retroviruses, human T-lymphotropic virus type III (HTLV-III) and 
lymphadenopathy-associated virus (LAV) helped to characterize the primary cellular 
receptor involved in HIV infection (Dalgleish et al., 1984; Klatzmann et al., 1984). Dalgleish 
and colleagues identified receptor-positive cells by assessing induction of multinucleated 
syncytia and by testing the susceptibility of various cell types to pseudotypes of vesicular 
stomatitis virus (VSV) carrying envelope antigens of HTLV strains. Their results showed 
that both VSV (HTLV-I) and VSV (HTLV-II) pseudotypes plated on a variety of cell types 
whereas the VSV (HTLV-III) was more specific to the two human T-cell lines (JM and CEM) 
tested. In addition, only cells expressing the CD4 antigen were sensitive to syncytium 
induction by HTLV-III and infection by VSV (HTLV-III) pseudotypes. After the screening of 
155 monoclonal antibodies to T-cell surface antigens for their ability to inhibit the syncytia 
formation induced by HTLV-III, they demonstrated that pre-incubation of cells with all anti-
CD4 antibodies blocked the cell fusion induced by HTLV-III. In another paper published the 
same year, Klatzman et al. (Klatzmann et al., 1984) investigated the relationship between the 
CD4+ tropism of LAV and the presence of CD4 on T lymphocytes. Similarly to the previous 
paper on HTLV-III, they reported that pre-incubation of CD4+ T lymphocytes with three 
monoclonal antibodies directed against the CD4 glycoprotein specifically blocked cell 
infection by LAV. 
It is well documented that efficient entry of HIV-1 into target cells is dependent upon 
binding of the viral exterior envelope glycoprotein, gp120, to the CD4-amino-terminal 
domain (McDougal et al., 1986). After the virus binding, the HIV-1 envelope glycoproteins 
mediate the fusion of viral and host cell membranes to complete the fusion process. The 
formation of syncytia results in the membrane fusion directed by HIV-1 envelope 
glycoproteins expressed on the infected cell surface with uninfected CD4-positive cells. 
Although CD4 expression on a target cell seems to be sufficient for HIV attachment, the 
fusion process appeared to be more complex. 
4.2 Secondary receptors of virus entry 
4.2.1 Chemokine receptors CXCR4 and CCR5 as HIV infection cofactors  
Chemokine receptors are part of the serpentine GTP-binding protein (G protein)-coupled 
receptors superfamily that include receptors for hormones, neurotransmitters, paracrine 
substance, inflammatory mediators, certain proteinases, taste and odorant molecules. All 
known human chemokines fit within four classes based on the cysteine motifs near the N-
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terminus. The two major classes are the CXC chemokines (CXCR1 to CXCR5) in which the 
first two cysteines are separated by a single residue, and the CC chemokines (CCR1 to 
CCR9) in which the first two cysteines are adjacent. CXCR4 (also termed fusin, HUMSTSR, 
LESTR, HM89, LCR1, NPYR, D2S201E) and CCR5 (also known as CKR5, CC CKR5, 
ChemR13, CMKBR5) are membrane-bound co-receptors for HIV entry. CXCR4 is expressed 
on neutrophils, myeloid cells (as well as microglia), and particularly on T lymphocytes 
(Loetscher et al., 1994). CCR5 mRNA expression was detected in lymphoid organs such as 
the thymus and spleen, and in peripheral T lymphocytes and macrophages (Raport et al., 
1996). The first HIV-1 co-receptor was identified with the use of a recombinant vaccinia 
virus-based construct in which fusion between the HIV gp120 envelope glycoprotein (Env)-
expressing cells and CD4-expressing cells would lead to the activation of a reporter gene 
Escherichia coli LacZ (Feng et al., 1996). The screening of a HeLa cDNA plasmid library and 
subsequent sequence analysis of the insert revealed that the protein was a member of the G 
protein-coupled receptor superfamily and was designated “fusin”. In addition, loss-of-
function experiments showed that anti-fusin antibodies blocked cell fusion and infection of 
primary human CD4+ T lymphocytes. Interestingly, both experiments stressed that fusin 
functioned preferentially for T cell line (TCL)-tropic rather than for macrophage (M)-tropic 
HIV-1 isolates. The discovery of fusin provided an impetus for the identification of the M-
tropic HIV isolates coreceptor. Several independent reports demonstrated that CCR5 is the 
major coreceptor for M-tropic HIV-1 strains (Alkhatib et al., 1996; Choe et al., 1996; Deng et 
al., 1996; Doranz et al., 1996; Dragic et al., 1996). The evidence was based on both gain-of-
function studies using recombinant CCR5, and loss-of-function studies with CCR5 
chemokines ligands (MCP-1, MIP-1, MIP-1 and RANTES) as blocking agents. After the 
discovery of CCR5, it was demonstrated that fusin is a chemokine receptor that specifically 
recognize the CXC chemokines ligands SDF-1 and SDF-1 (Bleul et al., 1996; Oberlin et al., 
1996); fusin was thus renamed CXCR4. 
4.2.2 Phosphatidylserine (PS), apoptotic blebs and virus spreading from cells to cells 
PS is a phospholipid located on the inner leaflet of the plasma membrane (Williamson and 
Schlegel, 1994; Zwaal and Schroit, 1997). Its internal positioning is maintained by 
translocases that catalyze aminophospholipid transport from the external to the internal 
leaflet of the plasma membrane. The loss of PS asymmetry can occur during several cellular 
events including cell injury, cell activation or apoptosis (Balasubramanian and Schroit, 
2003).  
Two apoptotic pathways can be identified; (i) the extrinsic apoptotic pathway is initiated by 
members of the Tumour necrosis factor (TNF) family of death ligands that bind to TNFR 
death receptor family members, Tumour Necrosis Factor Receptor –related apoptosis 
inducing signal ligand (TRAIL) and Fas ligand (FASL). This results in the formation of the 
Death Inducing Signal Complex DISC at the cell membrane. DISC subsequently interacts 
with Fas-associated death domain protein (FADD) in caspase 8, pro caspase 3 and this 
activates caspase 3, resulting in host cell death (Wilson et al., 2009); (ii) The intrinsic 
apoptosis pathway is dependent upon the activation of host proteins such as tumour 
suppressor protein P53 by virus infection. This in turn activates BH-3 domain only members 
of the B cell lymphoma 2 (Bcl-2) family, e.g the pro-apoptotic proteins Bax and Bak. The 
activation of these two proteins produces pores in the outer membrane of mitochondria 
with the release of cytochrome C activating caspase 9 and cell death (Danial and Korsmeyer, 
2004; Kroemer et al., 2007).  
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Apoptosis following viral infection is a robust  line defence mechanism, since the cell auto 
destruction appears one of the best ways to limit virus production and spreading  (Griffin 
and Hardwick, 1997). Unequivocally, the expected purpose of this cell suicide in response to 
infection is to short-circuit the viral expansion and to promote the clearance of dead infected 
cells by professional phagocytes (Fujimoto et al., 2000; Hashimoto et al., 2007). However, 
most viruses deal with this defensive reaction and have evolved strategies to evade or delay 
apoptosis (Teodoro and Branton, 1997).  
Under normal cellular conditions, exposure PS serves as a recognition signal for 
internalization of apoptotic cells or debris. PS-mediated apoptotic clearance is a highly 
conserved mechanism, occurring in both professional and nonprofessional phagocytes 
(Henson et al., 2001). Importantly, this process does not elicit an inflammatory response 
(Savill et al., 2002). “Apoptotic mimicry” or the exposure of PS on the surface of a pathogen 
provides a signal for virus uptake and may represent a mechanism for viruses to stunt the 
host inflammatory response and evade immune recognition. Some viruses like CMV or 
HSV-1 and HSV-2, which acquire their envelopes from intracellular organelles, have 
externalized PS (Pryzdial and Wright, 1994; Sutherland et al., 1997). A previous study 
investigated the early apoptotic events in real time in intact live ND7 neuron-like cells 
following HSV-1 infection  (Gautier et al., 2003). The authors demonstrated that infection of 
differentiated ND7 cells by HSV-1 triggers detectable alterations including PS exposure 
indicative of physiological changes associated with early stages of apoptosis.  
Furthermore, control of the apoptotic process by the viruses is key, either to establish a 
permanent infection when they are able to block apoptosis, or to facilitate their 
dissemination and prevent inflammatory and immune response when they are able to 
control and activate the late phase of apoptosis (Chen et al., 2006). Dissemination of viral 
particles through the production of apoptotic blebs from host cells could confer protection 
from the immune system (Chen et al., 2006; Everett and McFadden, 1999). Conversely, it has 
been proposed that phagocytosis of these pathogen (Sindbis for example) -enriched 
apoptotic blebs by antigen presenting cells (e.g. dendritic cells) could contribute to a robust 
and uncontrolled adaptive immune response leading to autoimmunity against self-antigens 
contained within the blebs (Rosen et al., 1995). In the case of CHIKV, it has recently been 
evidenced that completion of the apoptotic process is an important element for efficient 
virus propagation (Krejbich-Trotot et al., 2011). Indeed, CHIKV was revealed to exploit, may 
be in parallel to classical ways of entry and cell exit, an ingenious way of camouflage in 
apoptotic blebs to enhance viral spreading to neighbouring cells while being shielded from 
the immune system.  
4.2.3 The C-type lectin receptors and WNV cell entry  
The superfamily of proteins containing lectin-like domains is a large group of extracellular 
metazoan proteins with diverse functions (Zelensky and Gready, 2005). The main function 
of the calcium-dependent ‘C’-type lectins is to interact with pathogen-associated molecular 
patterns (PAMPs) which are well conserved and expressed by various microorganisms and 
to internalize these pathogens for processing and antigen presentation (Drickamer, 1995). 
For instance, C-type lectins contain Carbohydrate Recognition Domains (CRDs) capable of 
binding to conserved oligosaccharides that are commonly found on the surface 
glycoproteins of viruses (Cambi et al., 2005). C-type lectins are secreted as soluble proteins 
or produced as transmembrane proteins. The Mannan Binding Lectin (MBL), present in the 
plasma, is a member of the collectin family and is an example of soluble protein. MBL is 
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expressed by monocytes/microglia and possesses a globular carboxy terminal sequence that 
binds to virus proteins containing mannose molecules. The transmembrane lectins include 
the Mannose Membrane Receptor (MMR also known as CD206) and the Dentritic Cell-
Specific ICAM-3 Grabbing Non-integrin (DC-SIGN also known as CD209) receptor that 
recognizes “self “ intercellular adhesion molecule 2 (ICAM2) and ICAM3  (van Kooyk and 
Geijtenbeek, 2003). MMR contains eight CRD  (Weis et al., 1998). DC-SIGN is a type II 
transmembrane protein which possesses a single globular-structured CRD. DC-SIGN’s CRD 
is separated from the transmembrane region by a neck domain involved in oligomerization 
and which regulates carbohydrate specificity. Finally, a cytoplasmic tail is present, which 
includes internalization motifs and an incomplete immunoreceptor tyrosine-based 
activation motif (ITAM). Microglia, perivascular macrophages and dendritic cells express 
MMR and DC-SIGN (Burudi et al., 1999; Linehan et al., 1999; Mukhtar et al., 2002; Sallusto et 
al., 1995; Schwartz et al., 2002). The expression of DC-SIGN on brain microvascular 
endothelial cells could be advantageous for viral entry into the CNS (Mukhtar et al., 2002).  
Two major lineages of WNV, L1 and L2, have been identified after the phylogenetic analyses 
of glycoprotein E (Lanciotti et al., 1999). L1 strains have a large distribution and have been 
found in Africa, Europe, the Middle-East, North and Central America whereas the L2 strain 
is mainly localized in Africa and Madagascar. WNV human infection is usually 
asymptomatic, however life-threatening neurological disease, including encephalitis or 
meningitis, generally occurs in older or immunocompromised individuals (Campbell et al., 
2002; Granwehr et al., 2004). A recent study investigated the relative contribution of DC-
SIGN in infection by glycosylated L1 and non-glycosylated L1 and L2 strains (Martina et al., 
2008). The authors showed that in contrast to a non-glycosylated L1 strain, the glycosylated 
L1 strains use DC-SIGN as an attachment receptor on dendritic cells, leading to enhanced 
infection.  
4.2.4 Heparan sulfate proteoglycans (HSPGs) and HSV  
Heparan sulfate proteoglycans (HSPGs) are secreted and membrane associated proteins 
covalently attached to unbranched glycosaminoglycan heparan sulfate (HS) molecules 
which are composed of linear polysaccharide chains (Esko and Selleck, 2002). HS molecules 
are synthesized on a variety of cell surface proteins but are found consistently on members 
of two major families of membrane-bound proteoglycans: the transmembrane core proteins 
syndecans and the GPI-linked glypicans  (Bernfield et al., 1999). HS can influence cell-
environment interactions by binding to a heterogeneous group of growth factors, matrix 
ligands, and cell surface molecules. The possibility that HS could serve as an entry receptor 
for HSV type 1 and 2 was assessed on HEp-2 cells (WuDunn and Spear, 1989). They found 
that heparin blocked both virus adsorption. Different adsorption inhibitory agents 
including, heparin and poly-L-lysine (both bind to anions on the surface of virions and cells) 
and platelet factor 4 (which has a high affinity for heparin and heparan sulfate) was tested. 
After the incubation of these agents with HEp-2 cells either immediately before or during 
exposure with HSV-1 or HSV-2, an inhibition of virions adsorption by heparin was 
observed. Same results for poly-L-lysine and platelet factor 4 were obtained. A further study 
investigated the role of cell surface heparan sulfate in HSV infection using heparan sulfate-
deficient mutants CHO cells (Shieh et al., 1992). They demonstrated that CHO mutants with 
defect in heparan sulfate biosynthesis are resistant to HSV infection and have reduced 
numbers of receptor for HSV.  
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5. Innate immune responses against viral infection in the CNS 
The active and highly regulated control of immune responses in the brain is referred to as 
“immune privilege”. The  BBB, which prevents viruses, constituents of the adaptive immune 
system and antigen presenting cells, gaining accesses to the brain (for a review, see (Savarin 
and Bergmann, 2008)), is considered to be responsive for this privileged environment of the 
CNS. The CNS, therefore relies upon glia perivascular and meningeal cells to provide the 
innate immune response against virus attack (Hauwel et al., 2005). Microglia, astrocytes, 
ependymal cells, oligodendrocytes and neurons express Pattern Recognition Receptors 
(PRR)s (Suh et al., 2009) including the highly conserved Toll like receptors (TLR)s and the 
Retinoic inducible gene like RIG-1 receptors (RLRs) (Fujita et al., 2007) that detect the 
presence of ”non self “as represented by viral nucleic acids. 
5.1 TLRs  
The TLRs are PRRs that have unique and essential function in animal immunity. TLRs 
comprise a family of type I transmembrane receptors, which are characterized by an 
extracellular leucine-rich repeat (LRR) domain and an intracellular Toll-interleukin-1 
receptor (TIR) domain. LRR domains are found in a diverse set of proteins and mediate the 
recognition of components of foreign pathogens referred to as pathogen-associated 
molecular patterns (PAMPs) (for a review, see (Alexopoulou et al., 2001)). The cytoplasmic 
TIR domain of Toll proteins is a conserved protein-protein interaction module that is 
required for downstream signal transduction. So far, 10 and 12 functional TLRs have been 
identified in humans and mice, respectively, with TLR1-9 being conserved in both species 
(Takahashi et al., 2006). Microglia are the resident macrophages in the CNS and also express 
a wide range of TLRs (TLR1-9). Astrocytes express TLR1, 2, 3, 4, 5 and 9 whereas neurons 
mainly express TLR3 (Carty and Bowie, 2010). TLRs are located on the cell surface and are 
also distributed in the endosome so they are strategically placed to detect cytoplasmic viral 
RNA. TLR9 is activated by DNA rich in CpG motifs, whereas TLR7 and TLR8 recognize 
RNA viruses and ssRNA. TLR3 is activated by dsRNA formed during replication of viruses. 
TLRs signal through the adaptor molecules, myeloid differentiation primary response gene 
88 (MyD88) and Trif, to initiate intracellular signaling by transcription factors such as and 
the IFN regulatory factors (IRFs) (Alexopoulou et al., 2001). These IRFs are translocated to 
the host cell nucleus where they regulate inflammatory cytokine synthesis and stimulate 
type I interferon synthesis (IFN┙-┚ expression) to produce a protective response (anti-viral 
state) in adjacent uninfected cells (Paul et al., 2007). A further anti-viral property of the IRF 
is through its binding to the pro-apoptotic protein Bax and translocation to the mitochondria 
with activation of the mitochondrial apoptotic pathway, terminating virus replication 
(Chattopadhyay et al., 2010). Viruses can activate more than one TLR and it is known for 
example that TLR9 as well as TLR2 in dendritic cells and neuronal cells can respond to HSV 
to drive a protective IFN- antiviral response (Bereczky-Veress et al., 2010; Sato et al., 2006). 
RNA viruses such as HIV, Rabies and WNV are more likely to be recognized by TLR3 
and/or TLR7 or 8 expressed by microglia and neuronal cells (Prehaud et al., 2005; Szretter et 
al., 2010; Wang et al., 2004). The absence of TLR3 enhances WNV mortality in mice and 
increases viral burden in the brain (Daffis et al., 2008). Compared to wild-type controls, 
TLR3 -/- mice showed relatively little changes in peripheral viral loads. Interestingly, 
deficiency of TLR3 was associated with enhanced viral replication in primary cortical 
neuron cultures and greater WNV infection in neurons after intracranial inoculation while 
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no significant differences where noted in viral growth kinetics or IFN-alpha/beta induction 
between wild-type and TLR3 KO fibroblasts, macrophages, and dendritic cells.  
5.2 The RIG-I-like receptors (RLRs)  
After the discovery of TLRs, several classes of PRRs, including the RLRs were identified. 
The RLR family consists of the three RNA helicases members: retinoic inducible gene-I (RIG-
I), the melanoma differentiation-associated factor 5 (MDA5 also known as helicard or IFIH1) 
and the laboratory of genetics and physiology 2 (LGP2) that detect RNA viruses (Yoneyama 
and Fujita, 2009). RIG-I and MDA5 contain a C-terminal DExD/H box RNA helicase domain 
that is a characteristic amino acid signature motif of many RNA binding proteins, as well as 
two N-terminal caspase activation and recruitment domain (CARDs). LGP2 lacks CARD 
domains and has been proposed to function as a regulator of RIG-I/MDA5 signaling 
(Nakhaei et al., 2009). RIG-1 and MDA-5 are expressed by microglia and astrocytes, and 
located mainly in the cytosol and detect both short and long ds and ssRNA respectively 
(Furr et al., 2008; Hoarau et al., 2011). This interaction activates a series of intracellular 
signaling pathways using the adaptor molecules such as Interferon promoter stimulator 
(IPS-1) resulting in the transcription of IFN┙┚ interleukins and a range of anti-viral proteins. 
IPS-1 is key in the control of cell infection by several alphaviruses and flaviviruses including 
CHIKV and WNV, respectively. IPS-1-/- mice was recently shown to exhibit increased 
susceptibility to WNV infection marked by enhanced viral replication and dissemination 
with early viral entry into the CNS (Suthar et al., 2010). Moreover, infection of dendritic cells 
macrophages and primary cortical neurons showed that the IPS-1-dependent RLR signaling 
was essential for triggering IFN response (Suthar et al., 2010). Unexpectedly, infected KO 
mice also displayed uncontrolled inflammation that included elevated systemic type I IFN, 
proinflammatory cytokine and chemokine responses, increased numbers of inflammatory 
cells, enhanced humoral responses marked by complete loss of virus neutralization activity, 
and increased numbers of virus-specific CD8+ T cells and non-specific immune cell 
proliferation in the periphery and in the CNS. This uncontrolled inflammatory response was 
associated with a lack of regulatory T cell expansion that normally occurs during acute 
WNV infection. Thus, the enhanced inflammatory response in the absence of IPS-1 was 
coupled with a failure to protect against WNV infection. This is an important finding which 
stresses that IPS-1-dependent RLR signaling is equally important in the innate/adaptive 
immune responses but also in the balance of the immune response to WNV infection. With 
regards to CHIKV, it has recently been shown that IPS-1 is important at least in the 
periphery to drive a robust anti-viral response (Schilte et al., 2010).  
5.3 CNS Innate immune system; Interferon type 1 and 2 responses stimulate an anti-
viral response 
Mice deficient for the type I IFN receptor (IFNAR) has proved the fundamental importance 
of the type I IFN in the control of virus replication (Couderc et al., 2008; Muller et al., 1994). 
Indeed, CNS virus infections are more lethal in mice deficient in IFNAR than the wild type 
equivalent, emphasizing the importance of IFN/IFNAR pathway for anti-viral defense  
(Griffin, 2003; Paul et al., 2007). The type 1 interferon response is made by most CNS cells 
and results in a non-apoptotic anti-viral response by the host cell reducing infection by a 
replicating RNA virus (Katze et al., 2002). The IFN anti-viral response involves IFN binding 
to IFNAR on the host cell leading to the activation of Janus kinases (JAK) with 
phosphorylation of the activators of transcription factors (STAT1 and STAT2). These two 
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proteins enter the nucleus to drive the expression of interferon stimulated genes (ISGs) 
(Goodbourn et al., 2000) . Host CNS cells in response to IFN stimulation produces a range of 
anti-viral ISGs, including oligoadenylate synthetase (OAS) and IFN-inducible ds RNA –
dependent protein kinase (PKR) that both modulate virus replication; RNAse L and Mx that 
inhibit viral transcription together with the RNA deaminases (ADAR-1 and APOBEC3G) 
producing mutations in viral genomes  (Goodbourn et al., 2000) (George et al., 2009) (Toth et 
al., 2009). (IRFs) IRF-7, IRF-9, and ISG54 are all increased following CNS virus infection and 
one IRF, ISG15, has been found to be significantly increased in astrocytes following their 
infection with RNA virus (Paul et al., 2007). Type 2 interferon response is due to the 
interferon  again a glycoprotein expressed by activated T cells when TCR binds to their 
cognate antigen (Goodbourn et al., 2000). Many of the emerging viruses disable the host 
anti-viral response by targeting the pathways responsible for regulating IFN and anti-viral 
proteins. 
5.4 Phagocytosis and removal of infected cells 
The peculiarity of the CNS is that it is composed by a majority of cells that are non-
renewable. Hence, it is fundamental to rapidly clear the infected cells and limiting bystander 
effects and to reduce massive neuronal loss. Apoptotic cells must be rapidly cleared from 
the CNS because they contain neurotoxic proteins and viruses capable of increasing host 
tissue infection (Griffiths et al., 2009). Apoptotic cells express a range of non-self-molecules 
termed Apoptotic cell- associated molecular patterns  (ACAMPs)  on their surface and these 
molecules include sugars, nucleic acids, ribonucleoproteins and oxidized low density 
proteins. The best characterized ACAMP is the phosphatidylserine molecule (PS) (Fadok et 
al., 1998) (Savill et al., 2002). Glia and macrophages express a range of receptors including 
the phosphatidylserine receptor (PSR), CD14 and the Scavenger receptors (SR) divided into 
SRA ( SRA-1, SRA-II ) and SR B including CD36 all expressed by microglia (Areschoug and 
Gordon, 2009; Husemann et al., 2002; Savill et al., 2002) which are all involved in the 
selective recognition and clearance of apoptotic cells. It should be stressed that these 
receptors may also contribute in turn to the infection of phagocytic cells.  
5.5 Autophagy and control of viral infection 
Autophagy is a fundamental homeostatic process that leads to the degradation and 
recycling of long-lived cytoplasmic proteins and organelles (Klionsky, 2007) (Yoshimori, 
2004). The hallmark of autophagy is the formation of double or multiple membrane-bound 
vesicles called autophagosomes, which sequester a portion of the cytoplasm and fuse, after 
maturation, with lysosomes to digest their contents. In the same way, autophagy can also 
act directly, as an innate immune actor, to engulf and degrade pathogens. There is now 
some evidence for an antiviral role of autophagy related to viruses that specifically target 
neurons. The prototype virus studied was SINV, which is a positive-stranded RNA virus in 
the alphavirus genus. In mice, SINV produces fatal encephalitis that can be prevented by the 
cellular Bcl-2, an inhibitor of apoptotis (Levine et al., 1993). In a search to understand the 
mechanism by which Bcl-2 regulates Sindbis virus pathogenesis, a yeast two-hybrid 
screening was performed of a mouse brain library using Bcl-2 as bait, leading to the 
identification of a novel Bcl-2-interacting coiled-coil protein, Beclin 1. Beclin 1 is the 
mammalian homologue of yeast Atg6 and the first identified mammalian autophagy 
protein. Enforced neuronal expression of Beclin 1 was found to protect mice against fatal 
SINV encephalitis. In addition, Beclin reduces CNS SINV replication and viral-induced 
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neuronal apoptosis (Liang et al., 1998). The ability of enforced neuronal expression of Beclin 
1 to protect against lethal SINV  encephalitis suggests a protective role for autophagy in host 
defence against an emerging neurotropic infection. 
 
Fig. 1. Interactions between viruses and host cell receptors: Several receptors are known to 
interact with viruses and controling subsequent encephalitis. Some are receptors (e.g. CD4, 
CD46) involved in cell entry and signaling although the pathways which are engaged 
remain poorly characterized. Others are innate immune receptors such as RIG-I MDA5 and 
TLR which are expressed by neurons and glial cells (microglia and astrocyte) to initiate well-
described signaling pathways that converge at the activation of the transcription factors  
(IRF3/7 and/or nuclear factor-kB (NFkB)). These key events lead to the expression of type-I 
interferons (IFN-). The innate immune signaling pathways are intimately linked to 
apoptosis. The intrinsic apoptosis pathway is initiated by the release of cytochrome C from 
the mitochondria which promotes the formation of the apoptosome, including APAF-1 
(apoptotic protease activating factor) and caspase 9 which in turn activates the effector 
caspase 3. The extrinsic pathway mobilized notably by TNF-, TRAIL or FASL involves 
death-receptor signaling pathways linked to FADD and caspase 8. Some viruses can escape 
apoptosis by inducing the expression of anti-apoptotic proteins such as Bcl2. 
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6. Conclusion 
Despite the vast genetic diversity among viruses, these pathogens face similar obstacles on 
the way into the CNS with the dual role of a physical and molecular barriers of the innate 
immune system to restrict and protect from infection. However, upon entry whether they 
are hidden in leukocytes or in apoptotic blebs, they will be free to interact with neurons in a 
rather ‘immunopriviliged’ environnement allowing viral persistence. However, this 
paradigm has been reconsidered with the observation that resident cells possess several of 
the key innate immune receptors involved in the recognition of the intruders and to engage 
a salutary antiviral response (IFN). It is now clear that other molecular interactions between 
the viruses and these host cells expressing primary and secondary signaling receptors will 
determine the outcome of the infection. Some receptors may control apoptosis or cell 
differentiation which in turn may have an impact on the capacity to resist viral infection and 
spreading. Our understanding of the molecular mechanisms of CNS diseases is still in its 
infancy. Increasingly, identification of virulence factors and host receptors will provide 
solutions for this complex puzzle. Understanding these interactions will increase our ability 
to control neuroinvasion and encephalitis. Moreover, it will also teach how to use these 
entry routes for therapeutic benefit, for example, for gene delivery of therapy of cancer and 
neurodegeneration.  
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